The Eczema Area and Severity Index (EASI) is a highly complex tool for determining atopic dermatitis (AD) severity in the clinical setting. Here, an Investigator Global Assessment and body surface area product (IGAxBSA) were evaluated as a possible quicker and easier tool when measuring AD in pediatric patients.
Learn more at the Journal of the American Academy of Dermatology.